Revolutionary AI technology that analyzes oocyte spindle morphology to predict embryo ploidy and enhance IVF success rates.
🔬 Explore ReSpindle AI
AI-Driven Healthcare Innovation
We are a cutting-edge biotech company specializing in artificial intelligence solutions for reproductive medicine. Our team combines expertise in computer vision, machine learning, and clinical embryology to revolutionize IVF outcomes.
Advancing Reproductive Medicine
To provide clinicians with powerful AI tools that improve embryo selection accuracy, reduce the need for invasive genetic testing, and ultimately help more families achieve their dream of parenthood.
Expert Scientists & Engineers
Our multidisciplinary team brings together world-class expertise in embryology, AI research, and healthcare innovation. Each member contributes unique skills to advance reproductive medicine.
👥 Meet the Team
Live birth rate for women aged 35+ decreases dramatically. Major cause - increasing oocyte aneuploidy with age.
Advanced artificial intelligence technology that analyzes reproductive cell morphology to enhance IVF success rates through intelligent embryo selection.
Easy-to-use software that integrates directly with existing laboratory workflows and microscopy equipment for minimal disruption.
Access our professional AI technology for oocyte analysis. Advanced computer vision algorithms provide detailed ploidy predictions with confidence scores for clinical decision-making.
Gamow Tech B.V.
Brightlands Maastricht Health Campus
Oxfordlaan 55, 6229EV Maastricht
The Netherlands
Interested in integrating ReSpindle into your clinic? We offer flexible licensing options and comprehensive training programs for healthcare providers. Free AI access available for research purposes.
Telegram
WhatsApp